glp 1 patent expiration date Patents and regulatory exclusivities on GLP-1 receptor agonists India Tightens Checks On GLP-1

doi:10.1038/sj.ijo.0802206 61

Sometimes a UTI is the wake-up call that prompts better adherence to the prevention strategies that should have been in place from the start

And, as always, a new drug comes with some caveats and tradeoffs

Safety Revisited: Pancreas and Thyroid To close the loop on safety issues that have shadowed GLP-1 drugs: Pancreatitis/Pancreatic Cancer: Early on, especially around 2013, there were concerns that incretin therapies might increase pancreatitis risk or even pancreatic neoplasms (based on some animal data and analyses of FDA adverse event databases)

7.1 Comparing with the conventional hypoglycemic agents Compared with DDP-4i, GLP-1RAs showed better results in reducing the risk of cirrhosis and mortality (Yang et al., 2024)

Dietary Guidelines (20252030) reinforce a familiar direction in nutrition science: build meals around nutrient-dense, minimally processed foods